相关实验视频
Updated: Jun 28, 2025

10:00
Measurement of Lifespan in Drosophila melanogaster
Published on: January 7, 2013
34.3K
[在德国,没有功能限制的预期寿命是如何发展的? 用德国老龄化调查 (DEAS) 的数据进行分析]
Sonja Nowossadeck1, Enno Nowossadeck2, Fabian Tetzlaff2
1Deutsches Zentrum für Altersfragen, Manfred-von Richthofen-Str. 2, 12101, Berlin, Deutschland. sonja.nowossadeck@dza.de.
概括
健康预期寿命趋势显示,男性患病率压缩,女性患病率停滞或扩大. 这些发现突显了功能健康方面的性别差异,以及需要针对性干预来改善生活质量.
科学领域:
- 老年学是一门学科.
- 公共卫生 公共卫生
- 流行病学 流行病学
背景情况:
- 预期寿命的增加引发了人们对延长健康寿命以及寿命的担忧.
- 在没有功能和移动性限制的情况下,了解预期寿命的变化对于公共卫生政策至关重要.
研究的目的:
- 分析自2008年以来的无残疾预期寿命 (DFLE) 趋势及其在剩余预期寿命中的比例.
- 调查46岁和65岁时功能和运动限制的变化.
主要方法:
- 利用了来自德国老龄化调查 (2008年,2014年,2020/21年) 的数据.
- 使用沙利文方法计算DFLE.
- 评估严重的功能限制 (全球活动限制指标-GALI) 和运动限制 (爬楼梯,步行距离).
主要成果:
- 自2014年以来,在46岁和65岁的男性中观察到关于GALI的发病率压缩.
- 46岁和65岁的男性表现出运动压缩 (爬楼梯) 的趋势,46岁的男性表现出走路的趋势.
- 46岁和65岁的女性对GALI和爬楼梯的趋势停滞不前,46岁的女性在行走方面有所改善.
结论:
- 根据指标,年龄和性别,DFLE趋势有很大差异,表明没有普遍的病率压缩或扩张.
- 男性倾向于压缩发病率,而女性则表现出局限性的停滞或扩张.
- 调查结果强调了维护女性功能健康的挑战,以及提高健康预期寿命的有针对性的干预措施的必要性.
相关概念视频
Actuarial Approach
77
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
77
Kaplan-Meier Approach
133
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
133
Cancer Survival Analysis
345
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
345

